Cargando…
Protecting intellectual property associated with health technology trials – another barrier to multi-centre trials?
Autores principales: | Ross, Sue, Magee, Laura, Wood, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287769/ http://dx.doi.org/10.1186/1745-6215-12-S1-A52 |
Ejemplares similares
-
Protecting intellectual property associated with Canadian academic clinical trials - approaches and impact
por: Ross, Sue, et al.
Publicado: (2012) -
Evaluation of a site selection questionnaire for the recruitment of trial sites into multi-centre trials: experiences from the nottingham clinical trials unit
por: Whitham, Diane, et al.
Publicado: (2013) -
Methodological challenges designing pragmatic, multi-centre randomised controlled trials in critical care
por: MacLennan, Graeme, et al.
Publicado: (2013) -
Intellectual property on life sciences and biotechnology: state of affairs, impacts and perspectives
por: Avila, Jorge
Publicado: (2014) -
Comparative study of new imaging technologies for the diagnosis of glaucoma: design and conduct of a multi-centre diagnostic accuracy study
por: Banister, Katie, et al.
Publicado: (2013)